BWAY

Brainsway Ltd

BWAY.US brainsway.com
13.93
+0.02 (+0.14%)
USD · NASDAQ
52-week range
7.14
17.40
Trading at 66% of the 52-week range
Market Cap
560.10M
P/E Ratio
60.57
Forward P/E
18.55
Book Value
2.05
Div. Yield
N/A
% Institutions
32.51%
% Insiders
2.55%

1 Year

+77.5%

3 Year

+637.0%

10 Year

+151.2%
Description

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Company Information

Company Name
Brainsway Ltd
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US10501L1061
CIK: 0001076643
CUSIP: 10501L106
Currency: USD
Full Time Employees: 129
Phone: 972 2 582 4030
Fiscal Year End: December
IPO Date: Oct 06, 1999
Description:

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Address:

16 Hartum St, Jerusalem, Israel, 9777516

People

Directors & Officers

Name Title Year Born
Mr. Hadar Levy Chief Executive Officer 1974
Dr. David Zacut M.D. Co-Founder & Vice-Chairman 1953
Prof. Abraham Zangen Ph.D. Co-Founder, Member of Scientific Advisory Board & Director 1970
Mr. Ido Marom Chief Financial Officer 1976
Dr. Colleen Hanlon Ph.D. Vice President of Medical Affairs 1980
Mr. Michael Cohen Vice President of US Sales NA
Dr. Yiftach Roth Ph.D. Founder & Chief Scientific Officer 1971
Mr. Dor Hagai Vice President of Operations NA
Mr. Gilead Moiseyev Ph.D. Chief Technology Officer 1972
Mr. Menachem C. Klein Esq. VP, General Counsel & Corporate Secretary NA

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Valor Management LLC 5.31M Jun 30, 2026 13.22% $0.10 0.00%
Masters Capital Management LLC 1.50M Jun 30, 2026 3.73% $0.60 -9.09%
Acadian Asset Management LLC 818.27K Mar 31, 2026 2.04% $0.02 0.00%
Essex Investment Management Company, LLC 592.61K Jun 30, 2026 1.47% $1.20 -4.19%
Renaissance Technologies Corp 518.42K Mar 31, 2026 1.29% $0.01 -6.38%
Cresset Asset Management, LLC 314.92K Mar 31, 2026 0.78% $0.02 0.00%
Y.D. More Investments Ltd 272.00K Mar 31, 2026 0.68% $0.14 18.30%
SEI Investments Co 226.38K Mar 31, 2026 0.56% $0.00 81.24%
Legato Capital Management LLC 197.64K Jun 30, 2026 0.49% $0.25 2.85%
ARK Investment Management LLC 193.69K Mar 31, 2026 0.48% $0.02 -23.94%
Eagle Global Advisors, LLC 182.61K Jun 30, 2026 0.45% $0.09 5.79%
The Goldman Sachs Group Inc 107.71K Mar 31, 2026 0.27% $0.00 109.25%
Morgan Stanley - Brokerage Accounts 104.39K Mar 31, 2026 0.26% $0.00 13.08%
Sigma Planning Corp 100.44K Jun 30, 2026 0.25% $0.04 42.74%
Two Sigma Investments LLC 99.55K Jun 30, 2026 0.25% $0.00 -22.34%
Royce & Associates, LP 97.03K Mar 31, 2026 0.24% $0.01 0.00%
Huntleigh Advisors Inc 87.31K Jun 30, 2026 0.22% $0.19 7.10%
UBS Group AG 82.14K Mar 31, 2026 0.20% $0.00 21.44%
Trexquant Investment LP 77.15K Mar 31, 2026 0.19% $0.01 199.30%
Quadrature Capital Limited 63.09K Jun 30, 2026 0.16% $0.01 -17.46%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Timothy Plan Israel Common Values A 182.61K 0.45% ▲ 5.79% Jun 30, 2026
2 ARK Israel Innovative Technology ETF 146.85K 0.37% ▲ 0.00% Aug 31, 2026
3 1290 Essex Small Cap Growth I 138.59K 0.34% ▲ 0.00% Jul 31, 2026
4 Royce Smaller-Companies Growth Svc 97.00K 0.24% ▲ 0.00% Jun 30, 2026
5 Pleiades Small Cap Equity A 88.04K 0.22% ▼ 9.56% Jun 30, 2026
6 Amplify BlueStar Israel Technology ETF 74.45K 0.19% ▲ 0.00% Aug 31, 2026
7 Steward Values Enhanced International I 25.35K 0.06% ▲ 0.00% Jul 31, 2026
8 ActivePassive International Equity ETF 17.21K 0.04% ▲ 0.00% Aug 31, 2026
9 Mandarine Global Microcap G EUR 15.50K 0.04% ▲ 6.90% May 31, 2026
10 Even Herd Long Short ETF 14.99K 0.04% ▲ 0.00% Aug 31, 2026

Financial Highlights

Market Cap: $560.10M
EBITDA: $8.48M
P/E Ratio: $60.57
Book Value: $2.05
Earnings/Share: $0.23
Profit Margin: 15.56%
Operating Margin: 13.98%
ROA (TTM): 4.05%
ROE (TTM): 12.82%
Revenue (TTM): $60.70M
Revenue/Share (TTM): $1.61
Earnings Growth (YOY): 64.60%
Revenue Growth (YOY): 35.40%

Valuation Metrics

Enterprise Value: $510.25M
Trailing P/E: 60.57
Forward P/E: 18.55

Shares Statistics

Shares Outstanding: 40.21M
Shares Float: 23.25M
% Insiders: 2.55%
% Institutions: 32.51%
Short % Float: 0.68%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$52.23M
Cost of Goods Sold
adjust
$-12.84M
Gross Profit
subtotal
$39.39M
SG&A
adjust
$-6.53M
R&D
adjust
$-9.60M
Other Operating Expense
adjust
$-18.93M
Operating Income
subtotal
$4.32M
Other / Non-Operating Items
adjust
$3.31M
Net Income
subtotal
$7.63M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BWAY.US!